相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 免疫原:
该BioSIM 抗人 MUC1/CD227 抗体 (克利妥珠单抗),生物类似药,科研用途 [ CAS: 1622075-09-5]的免疫原请参考该产品的说明书
- 保存条件:
为确保适当储存,请避免反复冻融。短期需求(1-2周)请在4°C下保存;最长12个月的储存请在-20°C下保存。长期储存请在-80°C下保存。
- 克隆性:
单克隆
- 适应物种:
Human
- 保质期:
为确保适当储存,请避免反复冻融。短期需求(1-2周)请在4°C下保存;最长12个月的储存请在-20°C下保存。长期储存请在-80°C下保存。
- 级别:
科研级别
- 库存:
999
- 供应商:
亚科因(Abbkine)
- 宿主:
Humanized
- 应用范围:
ELISA, FACS, Functional assay, Research in vivo
- 抗体英文名:
MUC1/CD227
- 抗体名:
MUC1/CD227
- 规格:
5mg
产品基本信息与标识
英文全称:BioSIM anti-Human MUC1/CD227 Antibody (Clivatuzumab Biosimilar), Research Grade
中文全称:BioSIM 抗人 MUC1/CD227 抗体(克利妥珠单抗),生物类似药,科研用途
CAS登记号:1622075-09-5
产品货号:SIM0111-5mg
单支规格:5mg/支
品牌供应商:InvivoCrown
产品核心属性
- 产品类型:二抗试剂
- 来源宿主:人源化(Humanized)
- 物种反应性:仅针对人类(Human)组织/细胞样本
- 靶向分子:MUC1(黏蛋白1)/CD227
- 研究领域聚焦:胰腺癌相关基础研究
生产工艺与背景
背景说明:本产品为克利妥珠单抗(Clivatuzumab)的生物类似药,属于重组单克隆抗体类科研试剂。
关键生产工艺:
- 生产环境:全程在无动物成分的洁净生产设施中完成
- 细胞培养:采用体外无蛋白细胞培养技术,避免外源性蛋白污染
- 纯化流程:多步骤纯化工艺,包含Protein A或G亲和色谱核心步骤
适用科研应用场景
本抗体已验证可用于以下实验类型:
- 酶联免疫吸附实验(ELISA)
- 荧光激活细胞分选(FACS)
- 细胞功能学实验(Functional assay)
- 动物体内研究(Research in vivo)
保存与储存建议
为维持抗体活性稳定性,需严格遵循以下储存条件:
- 注意事项:避免反复冻融循环,以免影响抗体结构完整性
- 短期使用(1-2周内):4°C避光密封保存
- 中期储存(最长12个月):-20°C避光密封保存
- 长期储存(超过12个月):-80°C避光密封保存
重要说明
- 免疫原信息:具体免疫原序列及设计细节请参考产品配套说明书
- 用途限制:仅用于科学研究用途,不可用于临床诊断、治疗或人体试验
注意:以上信息可能随着产品优化升级等因素产生变动,具体信息请咨询亚科因公司。

Product Basic Information and Identification
Full English Name: BioSIM anti-Human MUC1/CD227 Antibody (Clivatuzumab Biosimilar), Research Grade
Full Chinese Name: BioSIM anti-Human MUC1/CD227 Antibody (Clivatuzumab), Biosimilar, Research Use
CAS Registry Number: 1622075-09-5
Product Catalog Number: SIM0111-5mg
Specification per Vial: 5mg/vial
Brand Supplier: InvivoCrown
Product Core Attributes
- Product Type: Secondary Antibody Reagent
- Source Host: Humanized
- Species Reactivity: Specific for human (Human) tissue/cell samples
- Target Molecule: MUC1 (Mucin 1)/CD227
- Research Field Focus: Basic research related to pancreatic cancer
Production Process and Background
Background Description: This product is a biosimilar of Clivatuzumab, belonging to the category of recombinant monoclonal antibody research reagents.
Key Production Process:
- Production Environment: Completed entirely in animal component-free clean production facilities
- Cell Culture: Utilizing in vitro protein-free cell culture technology to avoid exogenous protein contamination
- Purification Process: Multi-step purification process, including Protein A or G affinity chromatography as the core step
Applicable Research Application Scenarios
This antibody has been validated for use in the following experimental types:
- Enzyme-Linked Immunosorbent Assay (ELISA)
- Fluorescence-Activated Cell Sorting (FACS)
- Cell Functional Assay
- In vivo Animal Studies
Storage and Preservation Recommendations
To maintain antibody activity stability, the following storage conditions must be strictly followed:
- Important Notes: Avoid repeated freeze-thaw cycles to maintain antibody structural integrity
- Short-term use (within 1-2 weeks): Store sealed at 4°C protected from light
- Medium-term storage (up to 12 months): Store sealed at -20°C protected from light
- Long-term storage (over 12 months): Store sealed at -80°C protected from light
Important Notes
- Immunogen Information: For specific immunogen sequence and design details, please refer to the accompanying product manual
- Usage Limitation: For research use only, not for clinical diagnosis, treatment, or human trials
Note: The above information may change due to product optimization and upgrades. For specific information, please contact InvivoCrown.
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验
技术资料暂无技术资料 索取技术资料







